A Snapshot of Current Updates and Future Prospects of 3D Printing in Medical and Pharmaceutical Science.

Curr Pharm Des

Institute of Pharmaceutical Research (IPR), GLA University, NH-2, Mathura-Delhi Road, Chaumuhan, Mathura, 281406, U.P. India.

Published: May 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

3D printing in other fields, such as aviation, is quite old, but in the pharmaceutical area, it is an emerging technique. 3D printing is used to formulate various drug delivery systems and dosage forms with complex geometry. It allows large and fast production of products according to the need of the patient. Today, it is the widely used manufacturing technique in the healthcare field for the engineering of tissues and tissue models, production of medicines and medical devices, organ and tissue bioprinting, implant manufacturing, and production of polypills, vaginal rings, orodispersible films, etc. It allows the production of various dosage forms with complex release profiles containing multiple active ingredients. It is used for manufacturing medicines according to the need of individual patients focusing on the concept of personalized medicines. The idea of customized medicines allows change of dosage and design of the product as per individual and with decreased side effects. This review details various techniques of 3D printing used, such as stereolithography, fused deposition modeling, inkjet printing, etc., and applications and dosage forms developed with the latest patents. The significant challenges in the emergence of the 3D printing technique are the involvement of complex combinations to achieve desired properties, and also, the bioprinter involved provides slow and less resolution. The materials prepared by this technique are both biocompatible and printable, due to which additive manufacturing is increasing in the field of medicine.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612829666230228115442DOI Listing

Publication Analysis

Top Keywords

dosage forms
12
forms complex
8
printing
6
snapshot current
4
current updates
4
updates future
4
future prospects
4
prospects printing
4
printing medical
4
medical pharmaceutical
4

Similar Publications

Background: Candidiasis, predominantly caused by , poses a significant global health challenge, especially in tropical regions. Nystatin is a potent antifungal agent that is hindered by its low solubility and permeability, limiting its clinical efficacy.

Methods: This study aimed to investigate the potential of a layer-by-layer (LBL) coating system, employing chitosan and alginate, to improve the stability, entrapment efficiency (%EE), and antifungal efficacy of nystatin-loaded liposomes against Candida albicans.

View Article and Find Full Text PDF

Suspected relay pentobarbital intoxication of a dog after ingestion of contaminated tissue.

Can Vet J

September 2025

Emergency and Critical Care Department, New River Veterinary Specialists, 600 Argent Boulevard, Hardeeville, South Carolina 29927, USA (Graeber); Emergency and Critical Care Department, Veterinary Emergency and Critical Care, 8650 W. Tropicana Avenue B107, Las Vegas, Nevada 89147, USA (Weatherton).

Our objective was to describe a case of suspected relay barbiturate intoxication of a dog after ingestion of a rat that had been euthanized and frozen and then later burned in an attempted cremation. This case will be compared to previous reports of relay toxicosis. This report describes a dog that was presented to an emergency and critical care hospital because of lethargy and vomiting after ingesting remains of a rat that had been euthanized 2 wk earlier.

View Article and Find Full Text PDF

Time to face mask/spacer acceptance in dogs and cats.

Can Vet J

September 2025

Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, 200 Westboro Road, North Grafton, Massachusetts 01536, USA.

Objective: Aerosol medications are recommended for use in dogs and cats. Perceived pet intolerance to a face mask/spacer might prevent clinicians from recommending them, and thus prevent owners from using them. Our goal was to evaluate the duration required to train a pet to accept a face mask/spacer.

View Article and Find Full Text PDF

Ivermectin toxicosis in a foal: Use of intravenous lipid emulsion therapy.

Can Vet J

September 2025

Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, Florida 32608, USA (Darby, DeNotta, Gomez); Abu Dhabi Equine and Camel Hospital, Al Wathba, Abu Dhabi, United Arab Emirates (Gomez).

This report describes a case of ivermectin toxicosis in a 4-day-old thoroughbred colt successfully treated with intravenous lipid emulsion (ILE) without complications. This case supports the use of ILE as a safe and effective therapy for the management of lipophilic drug toxicosis in foals. Key clinical message: Ivermectin toxicosis, though rare in equine neonates, can occur following accidental overdose and induces severe neurologic signs.

View Article and Find Full Text PDF

Objective: The objective of this study was to comprehensively examine the real-world safety of esketamine using 58 months of postapproval data in the United States.

Methods: U.S.

View Article and Find Full Text PDF